Skip to main content
. 2023 Oct 5;14:1279329. doi: 10.3389/fimmu.2023.1279329

Table 1.

Timeline of the disease status and resulting/corresponding therapy in our case.

Age Disease status Therapy
15 months NOD2 mutation discovered.
Severe papular dermatitis, pruritus, arthritis, uveitis
Started on oral prednisolone 2 mg/kg/day for 8 weeks
17 months Resolved dermatitis, pruritus, arthritis, and uveitis Finished first course of oral steroids
19 months Recurrence of dermatitis, pruritus, arthritis, and uveitis Re-initiation of second course of oral prednisolone 2 mg/kg/day for 8 weeks
21 months Resolved dermatitis, pruritus, arthritis, and uveitis Finished second course of corticosteroids
22 months Recurrence of dermatitis, pruritus, arthritis, and uveitis Weaned off steroids
Started on 7.5 mg methotrexate subcutaneously weekly
+ 1 mg folic acid orally daily
24 months Improved dermatitis, but persistent arthritis, pruritus, and uveitis Started 75 mg daily hydroxychloroquine
26 months Resolved dermatitis, pruritus, arthritis, and uveitis Hydroxychloroquine discontinued due to desire to minimize long-term macular toxicity/risk for retinopathy
Continued on methotrexate 7.5 mg subcutaneously weekly
30 months Remains free of dermatitis, pruritus, arthritis, and uveitis Continuing 7.5 mg methotrexate subcutaneously weekly
+ 1 mg folic acid orally daily